Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Myeloid, Chronic-Phase 2Philadelphia Chromosome 1Neoplasm, Residual 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 83Peripheral Blood Stem Cell Transplantation 76fludarabine phosphate 74Busulfan 60Cyclosporine 57Imatinib Mesylate 50Mycophenolic Acid 49Antilymphocyte Serum 48Tacrolimus 44Radiotherapy 44Filgrastim 43Methotrexate 39Whole-Body Irradiation 34Dasatinib 34Methylprednisolone 30Cord Blood Stem Cell Transplantation 26nilotinib 25Melphalan 24Cytarabine 23Interferon-alpha 22Etoposide 20sargramostim 19Flow Cytometry 13Therapeutics 11Cyclosporins 11Sirolimus 10Polymerase Chain Reaction 10bosutinib 9Thiotepa 9Hydroxyurea 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Chronic-Phase × flumatinib × Clear all
NCT05367765 2022-05-10

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase 4 Not yet recruiting
2,400 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT04677439 2022-03-16

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Shenzhen Second People's Hospital

Phase 4 Unknown
200 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡